Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair
AUTOR(ES)
Schwartz, Ketty
FONTE
American Society for Clinical Investigation
RESUMO
It has long been noted that while patients with familial hypertrophic cardiomyopathy due to cardiac troponin T (cTnT) mutations often suffer sudden cardiac death, they do not develop significant ventricular hypertrophy, suggesting that a distinct cellular mechanism apart from alterations in myocardial contractility is responsible. A new study has revealed that a single missense mutation in cTnT causes a striking disruption to energy metabolism, leading to cardiomyopathy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=182216Documentos Relacionados
- Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function
- A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.
- Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.
- Familial hypertrophic cardiomyopathy: vectorcardiographic findings in echocardiographically unaffected relative.
- Genetic factors in familial hypertrophic cardiomyopathy: does molecular cardiology offer new perspectives?